BlackRock »

Aerovate Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.6M 983k 1.66
2024-03-31 $21M 710k 29.57
2023-09-30 $9.3M 683k 13.57
2023-06-30 $11M 623k 17.15
2023-03-31 $12M 600k 20.17
2022-12-31 $18M 608k 29.30
2022-06-30 $11M 705k 15.57